Andrew Kelly
Rheumatology · Philadelphia, PANPI 1588922215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $593 and has fallen 91.6% since, to $50 in 2025. That places this record below the midpoint for rheumatology clinicians in PA, where the typical reported total is $1,951.
Across 130 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$487
- Pfizer$290
- Johnson & Johnson$273
- Amgen$205
- GSK$197
- AstraZeneca$133
- plus $628 from 18 others
What the payments were for
- Food & beverage$2,19899%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $487 |
| Pfizer | 18 | $290 |
| Johnson & Johnson(2 entities) | 15 | $273 |
| Amgen | 12 | $205 |
| GSK | 12 | $197 |
| AstraZeneca(2 entities) | 7 | $133 |
| Aurinia Pharma U.S., Inc. | 4 | $80 |
| Novartis | 6 | $78 |
| Astellas Pharma US Inc | 3 | $76 |
| Genentech USA, Inc. | 4 | $53 |
| UCB, Inc. | 2 | $44 |
| Sobi, Inc | 2 | $38 |
| Mallinckrodt Enterprises LLC | 2 | $36 |
| Zimmer Biomet | 1 | $30 |
| Hikma Pharmaceuticals USA | 2 | $28 |
| Merck | 2 | $27 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Boehringer Ingelheim | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYNDAQEL$113
How this compares
$2,212 in reported general payments places this provider in the 50th percentile of 351 rheumatology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $134,775 |
| ActemraTocilizumab | 13 | $67,792 |
| Hydroxychloroquine Sulfate | 30 | $1,074 |
| MethotrexateMethotrexate Sodium | 30 | $656 |
| Colchicine | 11 | $641 |
| Gabapentin | 15 | $273 |
| Alendronate Sodium | 20 | $201 |
| Prednisone | 11 | $102 |
| Cyclobenzaprine Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Philadelphia
- Alan EpsteinPhiladelphia$1.2M
- Alexis Ogdie-BeattyPhiladelphia$433K
- Chris DerkPhiladelphia$66K
- Nora SandorfiPhiladelphia$52K
- Lawrence BrentPhiladelphia$22K
- Ethan CraigPhiladelphia$21K
- Monica LuchiPhiladelphia$20K
- Lawrence LeventhalHuntingdon Valley$1.1M
- Alan KivitzDuncansville$936K
- Paula HerringNewtown Square$920K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.